Jaguar Health, Inc. (JAGX) Return on equity 2017–2024
Jaguar Health, Inc. (JAGX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-592.7%FY2024 · since FY2017: -127.3% → -592.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -592.7% | -591.9 pp |
| FY2023 | -0.9% | — |
| FY2021 | -0.4% | +196.1 pp |
| FY2020 | -196.5% | +164.5 pp |
| FY2019 | -361.1% | +236.1 pp |
| FY2018 | -597.2% | -469.9 pp |
| FY2017 | -127.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More JAGX financial trends
JAGX RevenueJAGX Net incomeJAGX Net marginJAGX Gross profitJAGX Gross marginJAGX Operating incomeJAGX Operating marginJAGX Operating cash flowJAGX Free cash flowJAGX Capital expendituresJAGX Stock buybacksJAGX Dividends paidJAGX Total assetsJAGX Total liabilitiesJAGX Shareholders’ equityJAGX overview →